Overview
Neuralink represents the frontier of neural engineering, moving into 2026 with expanded clinical trials and early-stage commercial medical applications. The system utilizes the N1 implant, a 1,024-electrode array distributed across 64 ultra-thin threads, specifically designed to record and transmit neural signals wirelessly. These threads are implanted with micrometer precision by the R1 surgical robot to avoid the brain's vasculature. By 2026, the software architecture has matured to include a robust decoding layer that translates intent into high-fidelity digital actions, achieving bit rates that allow for fluid computer navigation, text entry, and device control for individuals with quadriplegia. The technical stack involves on-chip signal processing to filter neural spikes, low-energy Bluetooth transmission to an external receiver (typically a smartphone or tablet), and inductive charging. Market positioning has shifted from 'experimental' to 'transformative clinical intervention,' with the 2026 roadmap focusing on 'Blindsight' for visual restoration and broader integration with assistive ecosystems, establishing Neuralink as the gold standard for high-bandwidth brain-machine interfaces.